Azenta (AZTA) Q4 Earnings Top Estimates

Company Performance - Azenta reported quarterly earnings of $0.18 per share, exceeding the Zacks Consensus Estimate of $0.11 per share, and up from $0.13 per share a year ago, representing an earnings surprise of 63.64% [1] - Brooks, part of the Zacks Medical Info Systems industry, posted revenues of $170.06 million for the quarter ended September 2024, slightly missing the Zacks Consensus Estimate by 0.26%, and down from $172.36 million year-over-year [2] - Brooks has surpassed consensus EPS estimates four times over the last four quarters [2] Stock Performance - Brooks shares have declined approximately 29.6% since the beginning of the year, contrasting with the S&P 500's gain of 25.8% [3] - The current Zacks Rank for Brooks is 4 (Sell), indicating expected underperformance in the near future [6] Earnings Outlook - The current consensus EPS estimate for Brooks is $0.09 on revenues of $173.56 million for the upcoming quarter, and $0.42 on revenues of $703.29 million for the current fiscal year [7] - The trend for earnings estimate revisions for Brooks is currently unfavorable, which may impact future stock performance [6] Industry Context - The Medical Info Systems industry is ranked in the top 19% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]